[
    [
        {
            "time": "2021-07-28",
            "original_text": "Dow Jones Up 270 Points After Coca-Cola, Johnson & Johnson, Verizon Announce Earnings",
            "features": {
                "keywords": [
                    "Dow Jones",
                    "Coca-Cola",
                    "Johnson & Johnson",
                    "Verizon",
                    "Earnings"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "telecommunications",
                    "consumer goods"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Dow Jones Up 270 Points After Coca-Cola, Johnson & Johnson, Verizon Announce Earnings",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-07-29",
            "original_text": "Dow closes up more than 285 points as stocks extend rebound rally",
            "features": {
                "keywords": [
                    "Dow",
                    "rebound rally",
                    "stocks"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Dow closes up more than 285 points as stocks extend rebound rally",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 10,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-07-30",
            "original_text": "J&J CFO: Not-for-Profit Vaccine Price Likely to End in 2021",
            "features": {
                "keywords": [
                    "J&J",
                    "vaccine",
                    "price",
                    "CFO"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "J&J CFO: Not-for-Profit Vaccine Price Likely to End in 2021",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-30",
            "original_text": "J&J COVID-19 vaccine sales to total $2.5 billion in 2021",
            "features": {
                "keywords": [
                    "J&J",
                    "COVID-19",
                    "vaccine",
                    "sales"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "J&J COVID-19 vaccine sales to total $2.5 billion in 2021",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-07-30",
            "original_text": "US STOCKS-Wall Street rises on upbeat earnings, recovery optimism",
            "features": {
                "keywords": [
                    "US Stocks",
                    "Wall Street",
                    "earnings",
                    "optimism"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "US STOCKS-Wall Street rises on upbeat earnings, recovery optimism",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 10,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-30",
            "original_text": "Coke, J&J, Verizon All Beat on Q2 Numbers",
            "features": {
                "keywords": [
                    "Coke",
                    "J&J",
                    "Verizon",
                    "Q2 Numbers"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "telecommunications",
                    "consumer goods"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Coke, J&J, Verizon All Beat on Q2 Numbers",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-07-30",
            "original_text": "J&J Stock Rises on Earnings. Study Adds to Doubts Over Its Vaccine’s Efficacy.",
            "features": {
                "keywords": [
                    "J&J",
                    "Stock",
                    "Earnings",
                    "Vaccine",
                    "Efficacy"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "mixed",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "J&J Stock Rises on Earnings. Study Adds to Doubts Over Its Vaccine’s Efficacy.",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-07-30",
            "original_text": "Johnson & Johnson (JNJ) Q2 Earnings and Revenues Top Estimates",
            "features": {
                "keywords": [
                    "Johnson & Johnson",
                    "Q2",
                    "Earnings",
                    "Revenues",
                    "Estimates"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Johnson & Johnson (JNJ) Q2 Earnings and Revenues Top Estimates",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 10
            }
        }
    ]
]